Hasil Pencarian

✨ 14 results found - Searched 21704 records in 4ms.
cover

Tesis

Overall survival dan Disease Free Survival kanker serviks sel skuamosa vs adenokarsinoma stadium lanjut dikaitkan dengan respon radiasi
2019 | BY Ivolay Walasi Margret Dachi - ANDRIJONO
  • Overall survival and disease free survival of squamous cell carcinoma vs. adenocarcinoma advanced stage cervical carcinoma assosiated radiation response.
  • Nomor Panggil T19495fk
cover

Disertasi

PROFIL IMUNOFENOTIP, MUTASI GEN FLT3-ITD, NPM1, DAN CEBPA PADA LEUKEMIA MIELOID AKUT, SERTA HUBUNGANNYA DENGAN LUARAN KLINIS.
2015 | BY Abdul Muthalib - Siti Boedina Kresno - Agus Susanto Kosasih - Rahayuningsih Setiabudy
  • THE PROFILE OF IMMUNOPHENOTYPE, FLT3-ITD, NPM1 AND CEBPA GENE MUTATION IN ACUTE MYELOID LEUKEMIA AND ITS RELANTIONSHIP WITH CLINICAL OUTCOME.
  • Nomor Panggil D15031fk
cover

Disertasi

Peran MiR-10b, MiR-21, SuPAR dan PAI-1 Sebagai Prediktor Respons Terapi dan Progresivitas pada Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK).
2017 | BY Lyana Setiawan - Noorwati Sutandyo - Siti Boedina Kresno - Rahajuningsih Setiabudy
  • The Role of MiR-10b, MiR-21, Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), and Plasminogen Activator Inhibitor (PAI)-1 as Predictors of Treatment Response and Progressivity in Non-Small Cell Lung Cancer (NSCLC).
  • Nomor Panggil D17020fk
cover

Tesis

Luaran Terapi dan Faktor Prognostik Pasien Kanker Serviks IVB
2023 | BY Rainey Ahmad Fajri Putranta - Irwan Ramli - Arie Munandar - Muchtaruddin Mansyur - Ayu Santika Santaningrum
  • Outcome and Prognostic Factor for Cervical Cancer stage IVB Patients.
  • Nomor Panggil T23211fk
cover

Tesis

Analisis terapi afatinib pada adenokarsinoma paru dengan mutasi epidermal growth factor receptor (EGFR) di RSUP Persahabatan
2023 | BY Widya Angasreni - Sita Laksmi Andarini - Jamal Zaini
  • Therapy Analysis of afatinib in lung adenocarcinoma with epidermal growth factor receptor mutation (EGFR) at Persahabatan Hospital.
  • Nomor Panggil T23185fk
cover

Tesis

Profil Pasien Kanker Rektum yang Menjalani Radiasi di Departemen Radioterapi RSUPN Cipto Mangunkusumo Periode Tahun 2009 – 2014
2015 | BY Annisa Febi Indarti - Sri Mutya Sekarutami - Sahat Matondang
  • Profile of Rectal Cancer Patients Underwent Radiation Therapy in Department of Radiotherapy, National General Hospital of Cipto Mangunkusumo during Period of 2009 – 2014.
  • Nomor Panggil T 15 302 FK
cover

Tesis

Profil Pasien Glioma yang Menjalani Radiasi di RSUPN Dr. Cipto Mangunkusumo Tahun 2009-2014
2015 | BY Rika Ruhama - Sri Mutya Sekarutami - Rahmad Mulyadi
  • The Profile Of Glioma Patients Underwent Radiation Therapy In Cipto Mangunkusumo National Hospital Period 2009-2014.
  • Nomor Panggil T 15 260 FK
cover

Tesis

Efikasi Dan Toksisiti Kemoterapi Karboplatin-Vinorelbin Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut DI RSUP Persahabatan
2017 | BY Sita Laksmi Andarini - Jamal Zaini - Putu Ayu Diah Puspita Sari
  • Efficacy and Toxicity of Carboplatin-Vinorelbine Chemotherapy in advanced Non-small cell lung cancer (NSCLC) Patients at Persahabatan Hospital.
  • Nomor Panggil T17357fk
cover

Tesis

Efektivitas dan Keamanan Sorafenib Dosis Inisiasi 400 mg Dibandingkan Sorafenib Dosis Inisiasi 800 mg terhadap Kesintasan Pasien Karsinoma Sel Hati Stadium Lanjut dan Intermediet: Suatu Telaah Sistematis dan Meta-analisis
2021 | BY Roland Helmizar - Juferdy Kurniawan - Alvina Widhani - Rudi Putranto
  • Effectiveness and Safety of Sorafenib 400 mg Initial Dose Compared with Sorafenib 800 mg Initial Dose on Survival in Patients with Advanced and Intermediate Stage Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
  • Nomor Panggil T21339fk
cover

Tesis

Potensi Ekspresi Programmed Death Ligand-1 (PD-L1) pada Tumor Sel Germinal Ovarium Maligna (TSGOM) sebagai Faktor Prognostik
2019 | BY Fadhlina Muharmi Harahap - Hartono Tjahjadi - Kusmardi
  • The Potential of Programmed Death Ligand-1 (PD-L1) Expression in Malignant Ovarian Germ Cell Tumor as Prognostic Factor.
  • Nomor Panggil T19088fk